Načítá se...
Increasing the safety and efficacy of chimeric antigen receptor T cell therapy
Chimeric antigen receptor (CAR) T cell therapy is a promising cancer treatment that has recently been undergoing rapid development. However, there are still some major challenges, including precise tumor targeting to avoid off-target or “on-target/off-tumor” toxicity, adequate T cell infiltration an...
Uloženo v:
| Vydáno v: | Protein Cell |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Higher Education Press
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5546931/ https://ncbi.nlm.nih.gov/pubmed/28434147 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13238-017-0411-9 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|